-+ 0.00%
-+ 0.00%
-+ 0.00%

Kibow® Biotech Announces Availability of Renadyl® in Canada

Barchart·11/19/2026 12:00:00
Listen to the news

Expansion Brings Clinically Studied Kidney Probiotic to
More People Seeking to Maintain Kidney Health

EXTON, Pa., Nov. 19, 2026 /PRNewswire/ -- Kibow Biotech, a leading innovator in probiotic dietary supplements for kidney health, today announced the availability of its flagship product, Renadyl, in Canada, marking another important milestone in the company's mission to expand access to innovative, science-based kidney health solutions worldwide.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.